loading

Nachrichten werden geladen...

News zu #HZDR

Johanna Trommer and Tobias Krönke are part of the HZDR team that developed the special molecular marker.  © HZDR/K.Zheynova

New marker shows which bladder cancer patients benefit from therapy

Researchers at the Helmholtz-Zentrum Dresden-Rossendorf have developed a molecular marker to help doctors choose the right bladder cancer therapy. The radiotracer NECT-224 makes visible whether tumors carry a certain protein to which modern drugs can dock. In summer 2025, it was used successfully for the first time on a patient at Dresden University Hospital.

Brazil nuts not on the snack plate, but in the laboratory. Are they really healthy? © HZDR/B. Schröder

All-clear for Brazil nut fans

Brazil nuts are considered to be selenium bombs, but they also contain radioactive radium. Researchers from Dresden have now measured for the first time how much of it actually ends up in our bodies. The results reassure nut fans.